Last updated 2026-07-20
Total raised
—
Stage
Pre-Funding
Founded
2025
Headcount
10
HQ
Jerusalem, Israel
Sector
Health Tech & Life Sciences
About
GemCyclo Bio is developing novel orally available cyclic peptides that combine the benefits of small molecules and protein drugs. These peptides are designed to be easy to synthesize, have low immunogenicity, high affinity and selectivity to target active sites, and low off-target toxicity. The company holds a library of these cyclic peptides, targeting validated molecular pathways for immune and inflammatory diseases (I&I), cancer, and metabolic diseases.
Q&A
- When was GemCyclo Bio founded?
- GemCyclo Bio was founded in March 2025.
- What is GemCyclo Bio's primary focus?
- GemCyclo Bio is an early-stage biopharmaceutical company focused on developing orally available cyclic peptides for immune and inflammatory diseases, cancer, and metabolic diseases.
- What is the source of GemCyclo Bio's innovative drugs?
- The innovative new drugs are licensed from the Hebrew University of Jerusalem and designed using the proprietary Cycloscan technology by Prof Chaim Gilon and his colleagues.
- How many employees does GemCyclo Bio currently have?
- GemCyclo Bio currently has 1-10 employees.
- Who are the co-founders of GemCyclo Bio?
- The co-founders of GemCyclo Bio are Doron Friedman and Oron Yacoby - Zeevi.
- What is the current stage of GemCyclo Bio's product development?
- GemCyclo Bio's product development is currently in the R&D stage.
- What is GemCyclo Bio's current funding stage?
- GemCyclo Bio is currently in the Pre-Funding stage.
Team · 7
Dr. Doron Friedman
Founder · CEO & Co-Founder
Dr. Oron Yacoby-Zeevi
Founder · CSO & Co-Founder
Mr. Alon Blankstein
Founder · CFO & Co-Founder
Prof. Chaim Gilon
Founder · Academic Co-Founder
Prof. Amnon Hoffman
Founder · Academic Co-Founder
Prof. Philip Lazarovici
Founder · Academic Co-Founder
Prof. Gabriel Nussboum
Founder · Co-Founder
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Tags
drug-discoveryautoimmune-diseasesinflammatory-diseasesmetabolic-diseasepeptidescancer
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| linkedin.com/company/108629759 |
Identifiers & details
| Founded | 2025 |
|---|---|
| Employees (exact) | 10 |